Novozymes A/S (OTCMKTS:NVZMY) Hits New 12-Month High – Should You Buy?

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) reached a new 52-week high on Monday . The stock traded as high as $75.99 and last traded at $75.23, with a volume of 10550 shares changing hands. The stock had previously closed at $74.89.

Novozymes A/S Price Performance

The company has a market capitalization of $35.20 billion, a PE ratio of 47.57, a P/E/G ratio of 3.87 and a beta of 0.92. The company has a 50-day moving average of $66.75 and a two-hundred day moving average of $60.83.

About Novozymes A/S

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

See Also

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.